Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population

Archives of Toxicology

Volumn 81, Issue 10, 2007, Pages 711-718

  Ulusoy, Gulen ^a   Arinç, Emel ^a   Adali, Orhan ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Allele frequencies; CYP2E1 gene; CYP2E1*5B,*6,*7B; Genetic polymorphism; Turkish population

Indexed keywords

CYTOCHROME P450 2E1;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; CYTOCHROME P-450 CYP2E1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); TURKEY;

EID: 34547897290     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-007-0200-y     Document Type: Article

References (52)

1. Ada AO, Süzen SH, Iscan M (2004) Polymorphisms of cytochrome P450 1A1, gluthatione S-transferases M1 and T1 in a Turkish population. Toxicol Lett 151:311-315
2. Aktas D, Ozen H, Atsu N, Tekin A, Sozen S, Tuncbilek E (2001) Glutathione S-transferase M1 gene polymorphism in bladder cancer patients: a marker on invasive bladder cancer? Cancer Genet Cytogen 125:1-4
3. Arinç E, Adali O (1983) Solubilization and partial purification of 2 forms of cytochrome P-450 from trout liver microsomes. Comp Biochem Phys B 76:653-662
4. Arinç E, Adali O, Gencler-Ozkan AM (2000a) Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits. Arch Toxicol 74:329-334
5. Arinç E, Adali O, Gençler-Özkan AM (2000b) Stimulation of aniline, p-nitrophenol and N-nitrosodimethylamine metabolism in kidney by pyridine treatments of rabbits. Arch Toxicol 74:527-532
6. Arinç E, Arslan S, Adali O (2005) Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver. Arch Toxicol 79(8):427-433
7. Arinç E, Arslan S, Bozcaarmutlu A, Adali O (2007) Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food Chem Toxicol 45(1):107-118
8. Arinç E, Philpot RM (1976) Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J Biol Chem 25:3213-3220
9. Aynacioglu AS, Brockmoller J, Bauer S, Sachse C, Guzelbey P, Ongen Z, Nacak M, Roots I (1999) Frequency of cytochrome P4502C9 variants in a Turkish population and functional relevance for phenytoin. Br J Clin Pharmacol 48:409-415
10. Balta G, Yuksek N, Ozyurek E, Ertem U, Hicsonmez G, Altay C, Gurgey A (2003) Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 Genotypes in Childhood Acute Lymphoblastic Leukemia. Am J Hematol 71:154-160
11. Bolt HM, Roos PH, Thier R (2003) The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76:174-185
12. Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S (2000) Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 87:734-740
13. Brockmöller J, Cascorbi I, Kerb R, Roots I (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56(17):3915-3925
14. El-Zein R, Zwischenbergher JB, Wood TG, Abdel Rahman SZ, Brekelbaum C, Au WW (1997) Combined genetic polymorphism and risk for development of lung cancer. Mutat Res 381:189-200
15. Ernstgard L, Warholm M, Johanson G. (2004) Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity. Br J Clin Pharmacol 58(2):190-200
16. Fairbrother A, Grove J, de Waziers I, Steimel DT, Day CD, Crespi CL, Daly AK (1998) Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8:543-552
17. Farker K, Lehmann MH, Oelschlagel B, Haerting J, Hoffmann A, Janitzky V, Schubert J (1998) Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. Exp Toxicol Pathol 50:425-431
18. Garte S, Gaspari L, Alexandrie A-K, Ambrosone C, Autrup H, Autrup JI, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmöller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzana V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsich L-L, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, Lieshout EMM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WHM, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shileds PG, Sim E, Sinhet D, Strange RC, Stücker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev 10:1239-1248
19. Guengerich FP, Kim DH, Iwasaki M (1991) Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179
20. Haufroid V, Buchet JP, Gardinal S, Lison D (2002) Cytochrome P4502E1 phenotyping and the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene. Int Arch Occup Environ Health 75:453-458
21. Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIEI gene. J Biochem 110:559-565
22. Hong J-Y, Pan J, Gonzales FJ, Gelboin HV, Yang CS (1987) The induction of a specific form of cytochrome P-450 (P-450j) by fasting. Biochem Biophys Res Commun 142:1077-1083
23. Ingelman-Sundberg M, Johansson I, Yin H, Terelius Y, Eliason E, Clot P, Albano E (1993) Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 10:447-452
24. Johansson I, Ingelman-Sundberg M (1988) Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res 48(19):5387-5390
25. Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, Weston A, Harris CC (1992) Cytochrome P4502E1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 52:6712-6715
26. Kharasch ED, Thummel KE (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiol 79:795-807
27. Konishi T, Calvillo M, Leng A-S, Feng J, Lee T, Lee H, Smith JL, Sial SH, Berman N, French S, Eysselein V, Lin K-M, Wan Y-JY (2003) The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men. Exp Mol Pathol 74:183-189
28. Koop DR, Casazza JP (1985) Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J Biol Chem 260:13607-13612
29. Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77(2):517-543
30. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P (2001) Elucidation of CYP2E1 5′ regulatory RsaI/PstI allelic variants and their role in risk for oral cancer. Oral Oncol 37:437-445
31. Lu AYH, Levin W (1974) The resolution and reconstitution of the liver microsomal hydroxylation system. Biochem Biophys Acta 344:205-240
32. Neuhaus T, Ko Y-D, Lorenzen K, Fronhoffs S, Harth V, Bröde P, Vetter H, Bolt HM, Pesch B, Brüning T (2004) Association of cytochrome P450 2E1 Polymorphisms and head and neck squamous cell cancer. Toxicol Lett 151:273-282
33. Nishimoto IN, Hanaoka T, Sugimura H, Nagura K, Ihara M, Li X-J, Arai T, Hamada GS, Kowalski LB, Tsugane S (2000) Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: cas-control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Epidem Biomark Prev 9:675-680
34. Omer B, Ozbek U, Akkose A, Kilic G (2001) Genetic polymorphism of cytochrome P450 2E1 in the Turkish population. Cell Biochem Funct 19:273-275
35. Oyama T, Kawamato T, Mizoue T, Sugio K, Kodama Y, Mitsudomi T, Yasumoto K (1997) Cytochrome P4502E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res 17:583-588
36. Persson I, Johansson I, Lou YC, Yue QY, Duan LS, Bertilsson L, Ingelman-Sundberg M (1999) Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese kung cancer patients. Int J Cancer 81:325-329
37. Peter H, Deutschmann S, Reichel C, Hallier E (1989) Metabolism of methyl chloride by human erythrocytes. Arch Toxicol 72:454-455
38. Peter R, Böker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIEI. Chem Res Toxicol 3:566-573
39. Pinarbasi H, Silig Y, Seyfikli Z, Celik VK, Pinarbasi E (2001) Genetic polymorphism of GSTM1 in Turkish lung cancer patients. Toxicol Lett 123(Suppl 1):115
40. Quinones L, Lucas D, Godoy J, Caceres D, Berthou F, Varela N, Lee K, Acevedo C, Martinez L, Aguilera AM, Gil L (2001) CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174:35-44
41. Sikdar N, Mahmud ASk, Paul RR, Roy B (2003) Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 195(1):33-42
42. Song BJ, Matsunaga T, Hardwick JP, Park SS, Veech RL, Yang CS, Gelboin HV, Gonzales FJ (1987) Stabilization of cytochrome P450j messenger ribonucleic acid in the rat. Mol Endocrinol 1:542-547
43. Thier R, Lewalter J, Selinski S, Bolt HM (2002) Possible impact of human CYP2E1 polymorphisms on the metabolism of acrylonitrile. Toxicol Lett 128:249-255
44. Uematsu F, Ikawa S, Kikuchi H, Sagami I, Kanamaru R, Abe T, Satoh K, Motomiya M, Watanabe M (1994) Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenet 4(2):58-63
45. Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi T, Wakui A (1991) Association between restriction fragment length polymorphism of the human cytochrome P450 2E1 gene and susceptibility to lung cancer. Jpn J Cancer Res 82:254-256
46. Umeno M, McBridge OW, Yang CS, Gelboin HV, Gonzales FJ (1988) Human ethanol-inducible P450IIEI: complete gene sequence, promoter characterization, chromosome mapping and cDNA-directed expression. Biochemistry 27:9006-9013
47. Vodicka P, Soucek P, Tates AD, Dusinska M, Sarmanova J, Zamecnikova M, Vodickova L, Koskinen M, Zwart FA, Natajaran AT, Hemminki K (2001) Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res 482:89-103
48. Wang S-L, Lee H, Chen K-W, Tsai K-J, Chen C-Y, Lin P (1999) Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer 26:27-34
49. Watanabe J, Hayashi S, Nakachi K, Imai K, Suda Y, Sekine T, Kawajiri K (1990) PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res 18(23):7194
50. Wu X, Amos CI, Kemp BL, Shi H, Jiang H, Wan Y, Spitz MR (1998) Cytochrome P450 2E1 DraI polymorphism in lung cancer in minority populations. Cancer Epidemiol Biomark Prev 7:13-18
51. Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL, Spitz MR (1997) Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18(5):967-73
52. Yang B-M, O'Reilly DA, Demaine AG, Kingsnorth AN (2001) Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis. Alcohol 23:91-97